Rectal Prolapse Surgery in Switzerland: Hospital Volume and Patient Outcomes
NCT07929935, Completed, Lukas Marti
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Rectal Prolapse Surgery in Switzerland: Hospital Volume and Patient Outcomes | ClinicalTrials.gov |
| NCT number | NCT07929935 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Enrollment | 4,257 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Lukas Marti | ClinicalTrials.gov |
| Conditions | Prolapse, Switzerland, Outcome Assessment, Rectopexy, Mortality | ClinicalTrials.gov |
| Interventions | Surgical Treatment of Rectal Prolapse | ClinicalTrials.gov |
| First posted | 2026-11-10 | ClinicalTrials.gov |
| Last updated | 2026-11-10 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | In-Hospital mortality following rectal prolapse surgery | During the index hospitalization, from admission until hospital discharge or in-hospital death. As data from the Federal statistical office was completely anonymised no longer follow-up was possible. Mean length of stay was 7 days. | In-hospital mortality was defined as death from any cause during the index hospitalization following elective rectal prolapse surgery. Mortality was assessed using anonymized inpatient data from the Swiss Federal Statistical Office and analysed in relation to annual hospital procedure volume. | ClinicalTrials.gov |
| Secondary | Postoperative complication rate | During the index hospitalization, from admission until hospital discharge or in-hospital death. As data from the Federal statistical office was completely anonymised no longer follow-up was possible. Mean length of stay was 7 days. | Occurrence of postoperative complications during the index hospitalization following elective rectal prolapse surgery. Complications were identified using predefined ICD-10 and CHOP codes from the Swiss national inpatient database. | ClinicalTrials.gov |
| Secondary | Failure-to-rescue rate | During the index hospitalization, from admission until hospital discharge or in-hospital death. As data from the Federal statistical office was completely anonymised no longer follow-up was possible. Mean length of stay was 7 days. | Failure-to-rescue was defined as in-hospital death following at least one major postoperative complication. The rate was calculated as the proportion of patients with major complications who died during the index hospitalization. | ClinicalTrials.gov |
| Secondary | Length of hospital stay | During the index hospitalization, from admission until hospital discharge or in-hospital death. As data from the Federal statistical office was completely anonymised no longer follow-up was possible. Mean length of stay was 7 days. | Duration of the index hospitalization, measured in days. Length of stay was assessed using administrative inpatient data. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)